Neurological Sciences - 28 February is Rare disease day!
Enjoy reading featured articles in Neurological Sciences on the occasion of Rare disease day (this opens in a new tab)
Free access for non-Open Access articles listed below will last until March 31st 2022.
Nan, D., Zhang, Y., Han, J. et al. Clinical features and management of coexisting anti-N-methyl-D-aspartate receptor encephalitis and myelin oligodendrocyte glycoprotein antibody–associated encephalomyelitis: a case report and review of the literature. Neurol Sci 42, 847–855 (2021). https://doi.org/10.1007/s10072-020-04942-0 (this opens in a new tab)
Paolini Paoletti, F., Prontera, P., Nigro, P. et al. Small-expanded allele spinocerebellar ataxia 17: imaging and phenotypic variability. Neurol Sci 42, 4309–4315 (2021). https://doi.org/10.1007/s10072-021-05313-z (this opens in a new tab)
Ciaramitaro, P., Massimi, L., Bertuccio, A. et al. Diagnosis and treatment of Chiari malformation and syringomyelia in adults: international consensus document. Neurol Sci 43, 1327–1342 (2022). https://doi.org/10.1007/s10072-021-05347-3 (this opens in a new tab)
Murala, S., Nagarajan, E. & Bollu, P.C. Hereditary spastic paraplegia. Neurol Sci 42, 883–894 (2021). https://doi.org/10.1007/s10072-020-04981-7 (this opens in a new tab)
Messina, S., Sframeli, M., Maggi, L. et al. Spinal muscular atrophy: state of the art and new therapeutic strategies. Neurol Sci (2021). https://doi.org/10.1007/s10072-021-05258-3 (this opens in a new tab)
Shandilya, A., Mehan, S. Dysregulation of IGF-1/GLP-1 signaling in the progression of ALS: potential target activators and influences on neurological dysfunctions. Neurol Sci 42, 3145–3166 (2021). https://doi.org/10.1007/s10072-021-05328-6 (this opens in a new tab)
Di Stefano, V., De Angelis, M.V., Montemitro, C. et al. Clinical presentation of strokes confined to the insula: a systematic review of literature. Neurol Sci 42, 1697–1704 (2021). https://doi.org/10.1007/s10072-021-05109-1 (this opens in a new tab)
Bian, X., Wang, S., Jin, S. et al. Two novel missense variants in SPTBN2 likely associated with spinocerebellar ataxia type 5. Neurol Sci 42, 5195–5203 (2021). https://doi.org/10.1007/s10072-021-05204-3 (this opens in a new tab)
Pavanello, M., Fiaschi, P., Accogli, A. et al. A rare triad of morning glory disc anomaly, moyamoya vasculopathy, and transsphenoidal cephalocele: pathophysiological considerations and surgical management. Neurol Sci 42, 5433–5439 (2021). https://doi.org/10.1007/s10072-021-05221-2 (this opens in a new tab)
Ricciardi, D., Casagrande, S., Iodice, F. et al. Myasthenia gravis and telemedicine: a lesson from COVID-19 pandemic. Neurol Sci 42, 4889–4892 (2021). https://doi.org/10.1007/s10072-021-05566-8 (this opens in a new tab)
Zhang, J., Chen, Y., Chen, J. et al. AChRAb and MuSKAb double-seropositive myasthenia gravis: a distinct subtype?. Neurol Sci 42, 863–869 (2021). https://doi.org/10.1007/s10072-021-05042-3 (this opens in a new tab)
De Marchi, F., Carrarini, C., De Martino, A. et al. Cognitive dysfunction in amyotrophic lateral sclerosis: can we predict it?. Neurol Sci 42, 2211–2222 (2021). https://doi.org/10.1007/s10072-021-05188-0 (this opens in a new tab)